RedditBluesky
  • Home
  • Artificial Intelligence
  • Cryptocurrencies
  • Technology
  • Gold
  • Stocks
Home » News » Pfizer promotes COVID-19 pill.

Pfizer promotes COVID-19 pill.

Nearly 90% effective, company says, according to analysis

Gabriel ThomasOctober 5, 2026



On Tuesday, stocks fell globally and the US dollar rose to nearly a week-long high as investors nervously watched the Omicron coronavirus spread and anticipated numerous central bank decisions coming this week.

Wall Street fell and US Treasuries rose across the curve after US producer prices rose more than expected in November, another data point that supports the view that inflation may remain uncomfortably high for some time.

"As the year draws to a close, mixed messages continue to prevail," said Lindsey Bell, chief money and market strategist at Ally Invest. "The unexpectedly high PPI has perturbed the market, especially tech stocks. However, bond yields don't seem to be worried about inflation as the 10-year bond is 20 basis points below pre-Thanksgiving levels."

The US Federal Reserve is expected to announce on Wednesday that it is accelerating the end of its pandemic-era bond purchases and announcing a turn to rate hikes next year to protect itself from soaring inflation.

Several central banks will meet this week, starting Tuesday with the two-day meeting of the Federal Reserve, followed by the European Central Bank on Wednesday, the Bank of England on Thursday and the Bank of Japan on Friday.

While some investors sit on the sidelines and hesitate to take new positions before the end of the year, others remain happy to "buy the dent," a strategy that succeeded during the strong rally of 2021, said Benjamin Bowler, equity analyst at the Bank of America (NYSE: BAC).

"Markets can keep running as long as they think they are on solid ground and it's only when they look down that gravity kicks in," Bowler wrote in a note on Tuesday. "You can convince yourself for a while that a less supportive Fed is not going to derail the rally.

Bowler said this market rally, fueled in large part by the Fed's stimulating bond buying policy, poses real risk, especially as current levels of inflation could limit the Fed's ability to do so.

At 2:40 p.m. EST (1940 GMT) the MSCI index for stocks around the world lost 0.87% and the pan-European STOXX 600 index lost 0.84%.

The Dow Jones Industrial Average fell 97.14 points, or 0.27%, to 35,553.81, the S&P 500 fell 41.76 points, or 0.89%, to 4,627.21, and the Nasdaq Composite fell 225.83 points, or 1 , 47% to 15,187.45.

The rapidly expanding variant of Omicron also dampened sentiment on Wall Street after the S&P index hit an all-time high last week.

Emerging market stocks lost 0.8%. The broadest MSCI index for Asia-Pacific stocks outside of Japan closed 0.85% lower after the Asian Development Bank (ADB) cut its growth forecast for emerging Asia to reflect the risks of the new virus variant.

The Chinese CSI300 index fell 0.67% after health officials in Tianjin found the country's first Omicron case.

The dollar index rose 0.191% while the euro fell 0.22% to $ 1.1258. Given the expectation that the Fed will tighten its monetary policy faster than the ECB, the euro is considered vulnerable.

The US 10-year Treasury yield was 1.4411% and the 30-year Treasury bond yield was 1.826%.

US crude closed at $ 70.73 a barrel, down 56 cents, or 0.8%, and Brent closed 69 cents down at $ 73.70, down 0.9% for the day. is equivalent to. Oil prices are still far from the levels above $ 85 a barrel they reached in mid-October before the variant was discovered.

PfizerMedikamente





Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.


Claw and Order: Antimony Rules the Resource Realm
Read Next

Claw and Order: Antimony Rules the Resource Realm

  • RIDE THE BULL

    Your Front Row Seat to the Stories That Move Markets. – Subscribe Now to our Newsletter!

  • Trending Now

    • Mark Carney Single-Outs NexGen's Rook 1 as a Critical Project of National Interest
      Mark Carney Single-Outs NexGen's Rook 1 as a Critical Project of National Interest
    • Skyharbour Resources Advances Nasdaq Aspirations with Fresh Athabasca NI 43-101 Filings
      Skyharbour Resources Advances Nasdaq Aspirations with Fresh Athabasca NI 43-101 Filings
    • Amazon Inks 20-Year Deal with Constellation to Expand Clean Nuclear Capacity
      Amazon Inks 20-Year Deal with Constellation to Expand Clean Nuclear Capacity
    • Four for Four: Super Copper Logs Visible Copper at El Alto Target in Atacama
      Four for Four: Super Copper Logs Visible Copper at El Alto Target in Atacama

Claim Your Spot with Juniorstocks.com

Unlock the stories that move markets directly in your inbox


ContactDisclaimerData PrivacyTerms of Use
  • Bluesky
  • Reddit
Copyright 2026 ©Juniorstocks.com - All Rights Reserved.